Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.

NANot yet recruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Screening ColonoscopySurveillance Colonoscopy
Interventions
DIAGNOSTIC_TEST

MAGENTIQ-COLO.

This is a diagnostic performance study; no randomization will be conducted. All subjects will undergo the same study procedures. The endoscopist performing the examinations cannot be blinded for the output of the investigational device in this study. Due to the nature of the intervention, it is not guaranteed that the patient is not awake during the procedure, therefore blinding for the patient is also not feasible.

Trial Locations (5)

21202

Johns Hopkins Hospital, Baltimore

37403

Erlanger Health System, Chattanooga

91120

Hadassah Medical Organization, Jerusalem

Unknown

Assuta, Haifa

3000 CA

Erasmus Medical Center, Rotterdam

All Listed Sponsors
lead

Magentiq Eye LTD

INDUSTRY

NCT06568523 - Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy. | Biotech Hunter | Biotech Hunter